NCT02477072 - Optimized Heparin Regimen in Vascular Surgery | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions

Peripheral Revascularisation

Interventions

PROCEDURE

ACT

Blood samples for ACT will be collected following induction of anesthesia, 30 minutes after heparin administration, and on arrival in the recovery room.

PROCEDURE

TEG

Blood samples for TEG will be collected following induction of anesthesia, 30 minutes after heparin administration, and on arrival in the recovery room.

PROCEDURE

Ankle-brachial index

Peripheral blood flow will be assessed prior and after surgery using the ankle-brachial and toe-brachial indexes.

PROCEDURE

Toe-brachial index

Peripheral blood flow will be assessed prior and after surgery using the ankle-brachial and toe-brachial indexes.

DRUG

Heparin

Heparin doses will be administered according to the assigned group.

Trial Locations (1)

H2W 1T8

Centre Hospitalier de l'Université de Montréal (CHUM-Hôtel-Dieu), Montreal

All Listed Sponsors

lead

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER